Recruitment in Italy: Two Views

The Italian University recruitment system is definitely not efficient and malpractice occurs, but this happens more because of individual unethical and/or illegal behavior rather than being endemic, as alleged by Doncarli et al.1 Their main issue is the limitation on the number of papers submitted with the application. This is not peculiar to Italian selection committees; it is common in North America and concerns only papers that are physically submitted. Its purpose is to permit a judgment bas

Written byPaolo Rossi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Italian University recruitment system is definitely not efficient and malpractice occurs, but this happens more because of individual unethical and/or illegal behavior rather than being endemic, as alleged by Doncarli et al.1 Their main issue is the limitation on the number of papers submitted with the application. This is not peculiar to Italian selection committees; it is common in North America and concerns only papers that are physically submitted. Its purpose is to permit a judgment based not only on number of papers but also on quality of research, through self-evaluation and detailed screening of the (presumably) best papers. No selection process will ignore the number of papers and quality of the venues in which the papers are published.

The committees require full curriculum vitae for each candidate, including detailed academic histories, even votes from thesis committees and examinations, explanations of the candidate's research activities, and full bibliographies. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies